NCT01712490 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 664
- group Id
- BG001
- value
- 670
- group Id
- BG002
- value
- 1334
- units
- Participants
- groups
- description
- Brentuximab vedotin 1.2 milligram per kilogram (mg/kg), infusion, intravenously over 30-minutes plus doxorubicin 25 milligram per square meter (mg/m\^2), vinblastine 6 mg/m\^2, and dacarbazine 375 mg/m\^2, infusion, intravenously, once on Days 1 and 15 of each 28-day treatment cycle for up to a maximum of 6 cycles. Brentuximab vedotin was administered within approximately 1 hour after completion of AVD.
- id
- BG000
- title
- A+AVD
- description
- Doxorubicin 25 mg/m\^2, bleomycin 10 units per square meter (units/m\^2), vinblastine 6 mg/m\^2, and dacarbazine 375 mg/m\^2, infusion, intravenously, once on Days 1 and 15 of each 28-day treatment cycle for up to a maximum of 6 cycles.
- id
- BG001
- title
- ABVD
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.83
- value
- 38.8
- group Id
- BG001
- spread
- 16.05
- value
- 40.2
- group Id
- BG002
- spread
- 15.95
- value
- 39.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 286
- group Id
- BG001
- value
- 272
- group Id
- BG002
- value
- 558
- title
- Female
- measurements
- group Id
- BG000
- value
- 378
- group Id
- BG001
- value
- 398
- group Id
- BG002
- value
- 776
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 106
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 571
- group Id
- BG001
- value
- 577
- group Id
- BG002
- value
- 1148
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 45
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 560
- group Id
- BG001
- value
- 554
- group Id
- BG002
- value
- 1114
- title
- White
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 35
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 27
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- The intent-to-treat (ITT) population included all participants randomized to treatment.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 664
- group Id
- BG001
- value
- 670
- group Id
- BG002
- value
- 1334
- units
- Participants
- groups
- description
- Brentuximab vedotin 1.2 milligram per kilogram (mg/kg), infusion, intravenously over 30-minutes plus doxorubicin 25 milligram per square meter (mg/m\^2), vinblastine 6 mg/m\^2, and dacarbazine 375 mg/m\^2, infusion, intravenously, once on Days 1 and 15 of each 28-day treatment cycle for up to a maximum of 6 cycles. Brentuximab vedotin was administered within approximately 1 hour after completion of AVD.
- id
- BG000
- title
- A+AVD
- description
- Doxorubicin 25 mg/m\^2, bleomycin 10 units per square meter (units/m\^2), vinblastine 6 mg/m\^2, and dacarbazine 375 mg/m\^2, infusion, intravenously, once on Days 1 and 15 of each 28-day treatment cycle for up to a maximum of 6 cycles.
- id
- BG001
- title
- ABVD
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.83
- value
- 38.8
- group Id
- BG001
- spread
- 16.05
- value
- 40.2
- group Id
- BG002
- spread
- 15.95
- value
- 39.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 286
- group Id
- BG001
- value
- 272
- group Id
- BG002
- value
- 558
- title
- Female
- measurements
- group Id
- BG000
- value
- 378
- group Id
- BG001
- value
- 398
- group Id
- BG002
- value
- 776
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 106
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 571
- group Id
- BG001
- value
- 577
- group Id
- BG002
- value
- 1148
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 45
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 560
- group Id
- BG001
- value
- 554
- group Id
- BG002
- value
- 1114
- title
- White
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 35
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 27
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The ITT population included all participants randomized to treatment.
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- The intent-to-treat (ITT) population included all participants randomized to treatment.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle